March/April 2019 - Volume 42 - Issue 2 - Contributor Index

Alphabetical Search
A
E
F
O
P
Q
Author:
Bi, Yan PhD

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

Author:
Cao, Yanfei PhD

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

Author:
Deepak, MB MBBS
Author:
Du, Li PhD

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

Author:
He, Guang PhD

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

Author:
He, Lin PhD

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

Author:
Isik, Ümit MD
Author:
Li, Weidong PhD

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

Author:
Nitti, Kara MPH
Author:
Niu, Weibo PhD

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

Author:
Shah, Riddhi BS
Author:
Shi, Lei PhD

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

Author:
Wang, Lu MD

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

Author:
Wu, Xi PhD

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

Author:
Xu, Fei PhD

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

Author:
Xu, Yifeng PhD

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

Author:
Yu, Tao PhD

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

Author:
Yuan, Fan PhD

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

Author:
Yuan, Ruixue MD

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

Author:
Zhu, Liping PhD

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

Author:
Zhu, Yuhao MD

CYP1A2 Genetic Polymorphism Is Associated With Treatment Remission to Antidepressant Venlafaxine in Han Chinese Population

Zhu, Yuhao; Zhang, Naixing; Ren, Decheng; More

Clinical Neuropharmacology. 42(2):32-36, March/April 2019.

Show: